Case series and review of Ayurvedic medication induced liver injury

Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown 57% since 2002. CAM accounts for a significant proportion of drug induced liver injury in India and China, but there have been only three reports of dr...

Full description

Saved in:
Bibliographic Details
Published inBMC complementary and alternative medicine Vol. 21; no. 1; p. 91
Main Authors Karousatos, Christopher M, Lee, Justin K, Braxton, David R, Fong, Tse-Ling
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 13.03.2021
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown 57% since 2002. CAM accounts for a significant proportion of drug induced liver injury in India and China, but there have been only three reports of drug induced liver injury from Ayurvedic medications in the U.S. We report three cases of suspected Ayurvedic medication associated liver injury seen at a Southern California community hospital and review literature of Ayurvedic medication induced liver injury. Three patients presented with acute hepatocellular injury and jaundice after taking Ayurvedic supplements for 90-120 days. First patient took Giloy Kwath consisting solely of Tinospora cordifolia. Second patient took Manjishthadi Kwatham and Aragwadhi Kwatham, which contained 52 and 10 individual plant extracts, respectively. Third patient took Kanchnar Guggulu, containing 10 individual plant extracts. Aminotransferase activities decreased 50% in < 30 days and all 3 patients made a full recovery. Roussel Uclaf Causality Assessment Method (RUCAM) scores were 7-8, indicating probable causality. These products all contained ingredients in other Ayurvedic and traditional Chinese medicines with previously reported associations with drug induced liver injury. These patients highlight the risk of drug induced liver injury from Ayurvedic medications and the complexity of determining causality. There is a need for a platform like LiverTox.gov to catalog Ayurvedic ingredients causing liver damage.
AbstractList Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown 57% since 2002. CAM accounts for a significant proportion of drug induced liver injury in India and China, but there have been only three reports of drug induced liver injury from Ayurvedic medications in the U.S. We report three cases of suspected Ayurvedic medication associated liver injury seen at a Southern California community hospital and review literature of Ayurvedic medication induced liver injury. Three patients presented with acute hepatocellular injury and jaundice after taking Ayurvedic supplements for 90-120 days. First patient took Giloy Kwath consisting solely of Tinospora cordifolia. Second patient took Manjishthadi Kwatham and Aragwadhi Kwatham, which contained 52 and 10 individual plant extracts, respectively. Third patient took Kanchnar Guggulu, containing 10 individual plant extracts. Aminotransferase activities decreased 50% in < 30 days and all 3 patients made a full recovery. Roussel Uclaf Causality Assessment Method (RUCAM) scores were 7-8, indicating probable causality. These products all contained ingredients in other Ayurvedic and traditional Chinese medicines with previously reported associations with drug induced liver injury. These patients highlight the risk of drug induced liver injury from Ayurvedic medications and the complexity of determining causality. There is a need for a platform like LiverTox.gov to catalog Ayurvedic ingredients causing liver damage.
Background Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown 57% since 2002. CAM accounts for a significant proportion of drug induced liver injury in India and China, but there have been only three reports of drug induced liver injury from Ayurvedic medications in the U.S. We report three cases of suspected Ayurvedic medication associated liver injury seen at a Southern California community hospital and review literature of Ayurvedic medication induced liver injury. Case presentations Three patients presented with acute hepatocellular injury and jaundice after taking Ayurvedic supplements for 90–120 days. First patient took Giloy Kwath consisting solely of Tinospora cordifolia. Second patient took Manjishthadi Kwatham and Aragwadhi Kwatham, which contained 52 and 10 individual plant extracts, respectively. Third patient took Kanchnar Guggulu, containing 10 individual plant extracts. Aminotransferase activities decreased 50% in < 30 days and all 3 patients made a full recovery. Roussel Uclaf Causality Assessment Method (RUCAM) scores were 7–8, indicating probable causality. These products all contained ingredients in other Ayurvedic and traditional Chinese medicines with previously reported associations with drug induced liver injury. Conclusions These patients highlight the risk of drug induced liver injury from Ayurvedic medications and the complexity of determining causality. There is a need for a platform like LiverTox.gov to catalog Ayurvedic ingredients causing liver damage.
Background Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown 57% since 2002. CAM accounts for a significant proportion of drug induced liver injury in India and China, but there have been only three reports of drug induced liver injury from Ayurvedic medications in the U.S. We report three cases of suspected Ayurvedic medication associated liver injury seen at a Southern California community hospital and review literature of Ayurvedic medication induced liver injury. Case presentations Three patients presented with acute hepatocellular injury and jaundice after taking Ayurvedic supplements for 90-120 days. First patient took Giloy Kwath consisting solely of Tinospora cordifolia. Second patient took Manjishthadi Kwatham and Aragwadhi Kwatham, which contained 52 and 10 individual plant extracts, respectively. Third patient took Kanchnar Guggulu, containing 10 individual plant extracts. Aminotransferase activities decreased 50% in < 30 days and all 3 patients made a full recovery. Roussel Uclaf Causality Assessment Method (RUCAM) scores were 7-8, indicating probable causality. These products all contained ingredients in other Ayurvedic and traditional Chinese medicines with previously reported associations with drug induced liver injury. Conclusions These patients highlight the risk of drug induced liver injury from Ayurvedic medications and the complexity of determining causality. There is a need for a platform like LiverTox.gov to catalog Ayurvedic ingredients causing liver damage. Keywords: Ayurveda, Ayurvedic medicine, Drug induced liver injury (DILI), Herb induced liver injury (HILI), Traditional Chinese medicine, Roussel Uclaf causality assessment method
BACKGROUNDComplementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown 57% since 2002. CAM accounts for a significant proportion of drug induced liver injury in India and China, but there have been only three reports of drug induced liver injury from Ayurvedic medications in the U.S. We report three cases of suspected Ayurvedic medication associated liver injury seen at a Southern California community hospital and review literature of Ayurvedic medication induced liver injury. CASE PRESENTATIONSThree patients presented with acute hepatocellular injury and jaundice after taking Ayurvedic supplements for 90-120 days. First patient took Giloy Kwath consisting solely of Tinospora cordifolia. Second patient took Manjishthadi Kwatham and Aragwadhi Kwatham, which contained 52 and 10 individual plant extracts, respectively. Third patient took Kanchnar Guggulu, containing 10 individual plant extracts. Aminotransferase activities decreased 50% in < 30 days and all 3 patients made a full recovery. Roussel Uclaf Causality Assessment Method (RUCAM) scores were 7-8, indicating probable causality. These products all contained ingredients in other Ayurvedic and traditional Chinese medicines with previously reported associations with drug induced liver injury. CONCLUSIONSThese patients highlight the risk of drug induced liver injury from Ayurvedic medications and the complexity of determining causality. There is a need for a platform like LiverTox.gov to catalog Ayurvedic ingredients causing liver damage.
Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown 57% since 2002. CAM accounts for a significant proportion of drug induced liver injury in India and China, but there have been only three reports of drug induced liver injury from Ayurvedic medications in the U.S. We report three cases of suspected Ayurvedic medication associated liver injury seen at a Southern California community hospital and review literature of Ayurvedic medication induced liver injury. These patients highlight the risk of drug induced liver injury from Ayurvedic medications and the complexity of determining causality. There is a need for a platform like LiverTox.gov to catalog Ayurvedic ingredients causing liver damage.
Abstract Background Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown 57% since 2002. CAM accounts for a significant proportion of drug induced liver injury in India and China, but there have been only three reports of drug induced liver injury from Ayurvedic medications in the U.S. We report three cases of suspected Ayurvedic medication associated liver injury seen at a Southern California community hospital and review literature of Ayurvedic medication induced liver injury. Case presentations Three patients presented with acute hepatocellular injury and jaundice after taking Ayurvedic supplements for 90–120 days. First patient took Giloy Kwath consisting solely of Tinospora cordifolia. Second patient took Manjishthadi Kwatham and Aragwadhi Kwatham, which contained 52 and 10 individual plant extracts, respectively. Third patient took Kanchnar Guggulu, containing 10 individual plant extracts. Aminotransferase activities decreased 50% in < 30 days and all 3 patients made a full recovery. Roussel Uclaf Causality Assessment Method (RUCAM) scores were 7–8, indicating probable causality. These products all contained ingredients in other Ayurvedic and traditional Chinese medicines with previously reported associations with drug induced liver injury. Conclusions These patients highlight the risk of drug induced liver injury from Ayurvedic medications and the complexity of determining causality. There is a need for a platform like LiverTox.gov to catalog Ayurvedic ingredients causing liver damage.
Abstract Background Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown 57% since 2002. CAM accounts for a significant proportion of drug induced liver injury in India and China, but there have been only three reports of drug induced liver injury from Ayurvedic medications in the U.S. We report three cases of suspected Ayurvedic medication associated liver injury seen at a Southern California community hospital and review literature of Ayurvedic medication induced liver injury. Case presentations Three patients presented with acute hepatocellular injury and jaundice after taking Ayurvedic supplements for 90–120 days. First patient took Giloy Kwath consisting solely of Tinospora cordifolia. Second patient took Manjishthadi Kwatham and Aragwadhi Kwatham, which contained 52 and 10 individual plant extracts, respectively. Third patient took Kanchnar Guggulu, containing 10 individual plant extracts. Aminotransferase activities decreased 50% in < 30 days and all 3 patients made a full recovery. Roussel Uclaf Causality Assessment Method (RUCAM) scores were 7–8, indicating probable causality. These products all contained ingredients in other Ayurvedic and traditional Chinese medicines with previously reported associations with drug induced liver injury. Conclusions These patients highlight the risk of drug induced liver injury from Ayurvedic medications and the complexity of determining causality. There is a need for a platform like LiverTox.gov to catalog Ayurvedic ingredients causing liver damage.
ArticleNumber 91
Audience Academic
Author Karousatos, Christopher M
Fong, Tse-Ling
Lee, Justin K
Braxton, David R
Author_xml – sequence: 1
  givenname: Christopher M
  surname: Karousatos
  fullname: Karousatos, Christopher M
  organization: Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
– sequence: 2
  givenname: Justin K
  surname: Lee
  fullname: Lee, Justin K
  organization: Hoag Memorial Hospital Presbyterian, Newport Beach, CA, USA
– sequence: 3
  givenname: David R
  surname: Braxton
  fullname: Braxton, David R
  organization: Hoag Memorial Hospital Presbyterian, Newport Beach, CA, USA
– sequence: 4
  givenname: Tse-Ling
  orcidid: 0000-0001-9020-4880
  surname: Fong
  fullname: Fong, Tse-Ling
  email: tselingf@usc.edu, tselingf@usc.edu
  organization: Division of Gastrointestinal and Liver Diseases, Keck School of Medicine, University of Southern California, 1510 San Pablo Street, 2/F, Los Angeles, CA, 90033, USA. tselingf@usc.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33714265$$D View this record in MEDLINE/PubMed
BookMark eNptkl1rFDEUhoNUbK39A17IgCDeTM3HJJm5EZbFj0LBG70OmeRkN8tsUpOZle2vN9OtdVckkM_nvCc5eV-isxADIPSa4GtCWvEhE9phUWNKaswoJ_X9M3RBhaC1FJKcHc3P0VXOG4wxZYRJxl-gc8YkaajgF2i51BmqDMlDrnSwVYKdh19VdNViP6UdWG-q7dzr0cdQ-WAnA7Ya_A5SWW2mtH-Fnjs9ZLh6HC_Rj8-fvi-_1rffvtwsF7e14V0z1rLF1jS0peBsI7k1WlgOBgTTVvBeS9oT5gwHEIS4rrdSth0G6IjsheOYXaKbg66NeqPukt_qtFdRe_WwEdNK6TR6M4CSzvak6LTO9E0HXW90yUka6wQTruNF6-NB627qy_MMhDHp4UT09CT4tVrFnZIdL9ebBd4_CqT4c4I8qq3PBoZBB4hTVpRj0hRYyoK-_QfdxCmFUqqZooJ0mDV_qZUuD_DBxZLXzKJqITinpCFCFOr6P1RpFrbeFIs4X_ZPAt4dBaxBD-M6x2GafzOfgvQAmhRzTuCeikGwmi2nDpZTxXLqwXLqvgS9OS7jU8gfg7Hfi9TR1g
CitedBy_id crossref_primary_10_1016_j_jaim_2022_100635
crossref_primary_10_1016_j_jceh_2021_06_021
crossref_primary_10_3390_ph16081129
crossref_primary_10_18231_j_sajcrr_2024_003
crossref_primary_10_1016_j_jceh_2021_08_020
crossref_primary_10_4254_wjh_v13_i9_1019
crossref_primary_10_1016_j_jceh_2021_08_026
crossref_primary_10_1016_j_jceh_2021_09_009
crossref_primary_10_1002_cld_1135
crossref_primary_10_18311_jnr_2023_34070
crossref_primary_10_1007_s12664_024_01589_z
crossref_primary_10_3390_nu14224723
crossref_primary_10_1080_15569543_2021_1925696
crossref_primary_10_1016_j_jceh_2022_11_001
crossref_primary_10_4103_ijamr_ijamr_181_23
crossref_primary_10_1016_j_jceh_2021_11_014
crossref_primary_10_1055_s_0042_1758663
crossref_primary_10_2478_pjst_2023_0022
Cites_doi 10.1155/2012/504507
10.3390/ijms17010114
10.3390/ijms17010014
10.1111/j.1478-3231.2012.02864.x
10.1177/1534735419869479
10.1111/apt.12109
10.1002/hep.27317
10.1016/S1665-2681(19)30796-3
10.1186/1756-8722-4-51
10.1016/j.jep.2016.09.024
10.1016/j.jtcme.2016.02.002
10.4103/0022-3859.128819
10.1016/j.dld.2010.12.012
10.1111/apt.12798
10.1111/jgh.13323
10.1111/j.1468-1331.2011.03373.x
10.1007/s12664-017-0815-8
10.1136/bcr-2013-200958
10.4103/0975-9476.90769
10.1016/S1665-2681(19)31777-6
10.1007/0-306-48094-8_4
10.1089/acm.2008.0106
10.1097/MAJ.0b013e3181f41168
10.1111/head.12363
10.1016/j.healthpol.2008.09.003
10.1111/liv.14393
10.4321/S1130-01082005000200006
10.1016/j.toxrep.2020.02.008
10.1038/s41395-018-0154-0
10.1016/j.jep.2019.01.006
10.4254/wjh.v9.i31.1205
10.1002/jat.3283
ContentType Journal Article
Copyright COPYRIGHT 2021 BioMed Central Ltd.
2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2021
Copyright_xml – notice: COPYRIGHT 2021 BioMed Central Ltd.
– notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2021
DBID NPM
AAYXX
CITATION
3V.
7TK
7U7
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
C1K
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12906-021-03251-z
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
Neurosciences Abstracts
Toxicology Abstracts
Proquest Health & Medical Complete
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
AUTh Library subscriptions: ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
Toxicology Abstracts
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Central China
ProQuest Hospital Collection (Alumni)
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList PubMed
Publicly Available Content Database

MEDLINE - Academic


CrossRef

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: AUTh Library subscriptions: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2662-7671
1472-6882
EndPage 91
ExternalDocumentID oai_doaj_org_article_7fdb1e618fcb49e9bcad4714df636f95
A655214166
10_1186_s12906_021_03251_z
33714265
Genre Journal Article
GeographicLocations China
Timor-Leste
India
United States--US
GeographicLocations_xml – name: China
– name: India
– name: Timor-Leste
– name: United States--US
GroupedDBID 53G
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
ABUWG
ACRMQ
ADUKV
AFKRA
AFPKN
ALMA_UNASSIGNED_HOLDINGS
BENPR
BMC
C24
C6C
CCPQU
EBLON
EBS
EMB
EMOBN
FYUFA
GROUPED_DOAJ
HMCUK
IAO
IHR
IHW
INH
ITC
M1P
M~E
NPM
PGMZT
PIMPY
PSQYO
ROL
RPM
RSV
SOJ
SV3
UKHRP
AAYXX
CITATION
AFGXO
ABVAZ
AFNRJ
---
-A0
0R~
23N
2WC
3V.
5VS
6J9
6PF
7TK
7U7
7XB
8FK
A8Z
AAHBH
AAWTL
ACGFO
ACGFS
ACMJI
ACPRK
ADBBV
ADINQ
ADRAZ
AENEX
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
AMKLP
AOIJS
AZQEC
BAWUL
BCNDV
BFQNJ
BPHCQ
BVXVI
C1K
CS3
DIK
DU5
DWQXO
E3Z
F5P
GX1
HYE
INR
K9.
KQ8
O5R
O5S
OK1
P2P
PQEST
PQQKQ
PQUKI
PRINS
PROAC
RBZ
RNS
SMD
TR2
UNMZH
W2D
WOQ
WOW
XSB
7X8
5PM
ID FETCH-LOGICAL-c594t-780dc4282efd475dca6d5ece63ad65ba72b13fc5ee611f9bd77890ee917b6f503
IEDL.DBID RPM
ISSN 2662-7671
IngestDate Fri Oct 04 13:06:52 EDT 2024
Tue Sep 17 21:27:00 EDT 2024
Sat Aug 17 02:14:44 EDT 2024
Fri Sep 13 08:39:11 EDT 2024
Thu Feb 22 23:31:28 EST 2024
Sat Dec 16 00:16:22 EST 2023
Tue Aug 20 22:11:14 EDT 2024
Thu Sep 26 18:03:48 EDT 2024
Sat Sep 28 08:23:58 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Roussel Uclaf causality assessment method
Traditional Chinese medicine
Herb induced liver injury (HILI)
Ayurveda
Drug induced liver injury (DILI)
Ayurvedic medicine
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c594t-780dc4282efd475dca6d5ece63ad65ba72b13fc5ee611f9bd77890ee917b6f503
Notes ObjectType-Case Study-3
SourceType-Scholarly Journals-1
content type line 23
ObjectType-Review-1
ObjectType-Feature-5
ObjectType-Report-2
ObjectType-Article-4
ORCID 0000-0001-9020-4880
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956115/
PMID 33714265
PQID 2502619034
PQPubID 44230
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_7fdb1e618fcb49e9bcad4714df636f95
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7956115
proquest_miscellaneous_2501479577
proquest_journals_2502619034
gale_infotracmisc_A655214166
gale_infotracacademiconefile_A655214166
gale_healthsolutions_A655214166
crossref_primary_10_1186_s12906_021_03251_z
pubmed_primary_33714265
PublicationCentury 2000
PublicationDate 2021-03-13
PublicationDateYYYYMMDD 2021-03-13
PublicationDate_xml – month: 03
  year: 2021
  text: 2021-03-13
  day: 13
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC complementary and alternative medicine
PublicationTitleAlternate BMC Complement Med Ther
PublicationYear 2021
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References 3251_CR6
CA Philips (3251_CR27) 2018; 37
HC Chow (3251_CR33) 2019; 18
JH Byeon (3251_CR37) 2019; 233
3251_CR3
A Chaudhary (3251_CR7) 2011; 2
Y Zhu (3251_CR15) 2016; 31
VJ Navarro (3251_CR16) 2014; 60
YE Satow (3251_CR10) 2008; 14
3251_CR26
HA Oketch-Rabah (3251_CR36) 2020; 7
S Giri (3251_CR35) 2014; 60
C Bunchorntavakul (3251_CR34) 2013; 37
X Lin (3251_CR12) 2016; 36
A Shiyovich (3251_CR25) 2010; 340
YS Jaiswal (3251_CR5) 2016; 7
A Douros (3251_CR19) 2016; 17
HK Björnsson (3251_CR18) 2020; 40
T Smith (3251_CR8) 2019; 123
H Tremlett (3251_CR23) 2011; 18
PK Mukherjee (3251_CR1) 2017; 197
RL Nahin (3251_CR9) 2016; 95
KK Dalal (3251_CR29) 2017; 9
J Xu (3251_CR13) 2009; 90
R Teschke (3251_CR20) 2009; 8
R Teschke (3251_CR28) 2012; 32
PM Barnes (3251_CR4) 2008; 12
CA Philips (3251_CR11) 2019; 7
DA Smith (3251_CR21) 2014; 2014
R Teschke (3251_CR32) 2014; 40
KS Gunturu (3251_CR30) 2011; 4
R Teschke (3251_CR31) 2015; 14
S Dantuluri (3251_CR22) 2011; 43
T Gokani (3251_CR2) 2014; 54
CA Philips (3251_CR17) 2018; 113
JL McQuade (3251_CR14) 2012; 2012
OA Jorge (3251_CR24) 2005; 97
References_xml – volume: 2012
  start-page: 504507
  year: 2012
  ident: 3251_CR14
  publication-title: Evid Based Complement Alternat Med
  doi: 10.1155/2012/504507
  contributor:
    fullname: JL McQuade
– volume: 17
  start-page: 114
  issue: 1
  year: 2016
  ident: 3251_CR19
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms17010114
  contributor:
    fullname: A Douros
– ident: 3251_CR26
  doi: 10.3390/ijms17010014
– volume: 32
  start-page: 1543
  issue: 10
  year: 2012
  ident: 3251_CR28
  publication-title: Liver Int
  doi: 10.1111/j.1478-3231.2012.02864.x
  contributor:
    fullname: R Teschke
– volume: 18
  start-page: 153473541986947
  year: 2019
  ident: 3251_CR33
  publication-title: Integr Cancer Ther
  doi: 10.1177/1534735419869479
  contributor:
    fullname: HC Chow
– volume: 37
  start-page: 3
  issue: 1
  year: 2013
  ident: 3251_CR34
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/apt.12109
  contributor:
    fullname: C Bunchorntavakul
– volume: 12
  start-page: 1
  year: 2008
  ident: 3251_CR4
  publication-title: Natl Health Stat Report.
  contributor:
    fullname: PM Barnes
– volume: 60
  start-page: 1399
  issue: 4
  year: 2014
  ident: 3251_CR16
  publication-title: Hepatology.
  doi: 10.1002/hep.27317
  contributor:
    fullname: VJ Navarro
– volume: 14
  start-page: 7
  issue: 1
  year: 2015
  ident: 3251_CR31
  publication-title: Ann Hepatol
  doi: 10.1016/S1665-2681(19)30796-3
  contributor:
    fullname: R Teschke
– volume: 123
  start-page: 62
  year: 2019
  ident: 3251_CR8
  publication-title: American Botanical Council
  contributor:
    fullname: T Smith
– volume: 7
  start-page: 263
  issue: 3
  year: 2019
  ident: 3251_CR11
  publication-title: J Clin Transl Hepatol
  contributor:
    fullname: CA Philips
– volume: 4
  start-page: 51
  year: 2011
  ident: 3251_CR30
  publication-title: J Hematol Oncol
  doi: 10.1186/1756-8722-4-51
  contributor:
    fullname: KS Gunturu
– volume: 197
  start-page: 10
  year: 2017
  ident: 3251_CR1
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2016.09.024
  contributor:
    fullname: PK Mukherjee
– volume: 7
  start-page: 50
  issue: 1
  year: 2016
  ident: 3251_CR5
  publication-title: J Tradit Complement Med
  doi: 10.1016/j.jtcme.2016.02.002
  contributor:
    fullname: YS Jaiswal
– volume: 60
  start-page: 72
  issue: 1
  year: 2014
  ident: 3251_CR35
  publication-title: J Postgrad Med
  doi: 10.4103/0022-3859.128819
  contributor:
    fullname: S Giri
– volume: 43
  start-page: 500
  issue: 6
  year: 2011
  ident: 3251_CR22
  publication-title: Dig Liver Dis
  doi: 10.1016/j.dld.2010.12.012
  contributor:
    fullname: S Dantuluri
– volume: 40
  start-page: 32
  issue: 1
  year: 2014
  ident: 3251_CR32
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/apt.12798
  contributor:
    fullname: R Teschke
– volume: 31
  start-page: 1476
  issue: 8
  year: 2016
  ident: 3251_CR15
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/jgh.13323
  contributor:
    fullname: Y Zhu
– volume: 18
  start-page: e78
  issue: 7
  year: 2011
  ident: 3251_CR23
  publication-title: Eur J Neurol
  doi: 10.1111/j.1468-1331.2011.03373.x
  contributor:
    fullname: H Tremlett
– volume: 37
  start-page: 9
  issue: 1
  year: 2018
  ident: 3251_CR27
  publication-title: Indian J Gastroenterol
  doi: 10.1007/s12664-017-0815-8
  contributor:
    fullname: CA Philips
– volume: 2014
  start-page: bcr2013200958
  year: 2014
  ident: 3251_CR21
  publication-title: BMJ Case Rep
  doi: 10.1136/bcr-2013-200958
  contributor:
    fullname: DA Smith
– volume: 2
  start-page: 179
  issue: 4
  year: 2011
  ident: 3251_CR7
  publication-title: J Ayurveda Integr Med
  doi: 10.4103/0975-9476.90769
  contributor:
    fullname: A Chaudhary
– volume: 8
  start-page: 258
  issue: 3
  year: 2009
  ident: 3251_CR20
  publication-title: Ann Hepatol
  doi: 10.1016/S1665-2681(19)31777-6
  contributor:
    fullname: R Teschke
– ident: 3251_CR3
  doi: 10.1007/0-306-48094-8_4
– volume: 14
  start-page: 1249
  issue: 10
  year: 2008
  ident: 3251_CR10
  publication-title: J Altern Complement Med
  doi: 10.1089/acm.2008.0106
  contributor:
    fullname: YE Satow
– volume: 340
  start-page: 514
  issue: 6
  year: 2010
  ident: 3251_CR25
  publication-title: Am J Med Sci
  doi: 10.1097/MAJ.0b013e3181f41168
  contributor:
    fullname: A Shiyovich
– volume: 54
  start-page: 1103
  issue: 6
  year: 2014
  ident: 3251_CR2
  publication-title: Headache.
  doi: 10.1111/head.12363
  contributor:
    fullname: T Gokani
– volume: 90
  start-page: 133
  issue: 2–3
  year: 2009
  ident: 3251_CR13
  publication-title: Health Policy
  doi: 10.1016/j.healthpol.2008.09.003
  contributor:
    fullname: J Xu
– volume: 95
  start-page: 1
  year: 2016
  ident: 3251_CR9
  publication-title: Natl Health Stat Report
  contributor:
    fullname: RL Nahin
– ident: 3251_CR6
– volume: 40
  start-page: 825
  issue: 4
  year: 2020
  ident: 3251_CR18
  publication-title: Liver Int
  doi: 10.1111/liv.14393
  contributor:
    fullname: HK Björnsson
– volume: 97
  start-page: 115
  issue: 2
  year: 2005
  ident: 3251_CR24
  publication-title: Rev Esp Enferm Dig
  doi: 10.4321/S1130-01082005000200006
  contributor:
    fullname: OA Jorge
– volume: 7
  start-page: 386
  year: 2020
  ident: 3251_CR36
  publication-title: Toxicol Rep
  doi: 10.1016/j.toxrep.2020.02.008
  contributor:
    fullname: HA Oketch-Rabah
– volume: 113
  start-page: 1260
  issue: 8
  year: 2018
  ident: 3251_CR17
  publication-title: Am J Gastroenterol
  doi: 10.1038/s41395-018-0154-0
  contributor:
    fullname: CA Philips
– volume: 233
  start-page: 190
  year: 2019
  ident: 3251_CR37
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2019.01.006
  contributor:
    fullname: JH Byeon
– volume: 9
  start-page: 1205
  issue: 31
  year: 2017
  ident: 3251_CR29
  publication-title: World J Hepatol
  doi: 10.4254/wjh.v9.i31.1205
  contributor:
    fullname: KK Dalal
– volume: 36
  start-page: 1163
  issue: 9
  year: 2016
  ident: 3251_CR12
  publication-title: J Appl Toxicol
  doi: 10.1002/jat.3283
  contributor:
    fullname: X Lin
SSID ssj0002313735
ssj0017814
Score 2.2731743
SecondaryResourceType review_article
Snippet Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown 57% since...
Abstract Background Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States...
Background Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown...
BACKGROUNDComplementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown...
Abstract Background Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 91
SubjectTerms Abdomen
Alternative medicine
Antibodies
Asian Americans
Ayurveda
Ayurvedic medicine
Bile
Biological products
Case Report
Case reports
Causality
Chinese medicine
Dietary supplements
Drug induced liver injury (DILI)
Drugs
Flowers & plants
Hepatitis A
Herb induced liver injury (HILI)
Herbal medicine
Hypothyroidism
Ingredients
Injuries
Jaundice
Literature reviews
Liver
Liver diseases
Medicine, Ayurvedic
Medicine, Chinese
Patients
Plant extracts
Roussel Uclaf causality assessment method
Traditional Chinese medicine
Ultrasonic imaging
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LixQxEA6yB_Eirs92V40geJBmO51X5zgOLouwnlzYW8gTXaRHdmYE99dblfQM03jw4rEnNU3nq1SqqlP1NSHvQj-wnPvUCs1dK7yDfTAr03aReZVNYD7jie7lF3VxJT5fy-uDT31hTVilB67AnekcPUuKDTl4YZLxwUXYUEXMisPNKnspkwfJ1E0hcWFcc7nrkhnU2RpfuGC9LVYQgVNv72aeqBD2_70tH_ilec3kgRM6f0QeTtEjXdSnPib30viY3L-czsefkOUSnBLFVZXW1I2R1s4Uusp08Xt7-wsFaTlOLwqhkJCDaiP9gdUZcHUDCD8lV-efvi4v2ukzCW2QRmxaPXQxQBbRpwzIyBicijKFpLiLSgL6vWc8B5kARZaNjxqbX1OCRA3UITv-jByNqzG9IFSD-4bbZO2MEUjUHgcIUDo-OKP72PmGfNhBZn9WNgxbsohB2QqwBYBtAdjeNeQjorqXRCbr8gPo1076tf_Sb0PeoE5sbQvd26NdKAmRB4STqiHviwRaJKgmuKmxAKaE3FYzydOZJFhSmA_v9G4nS15bCBExyey4aMjb_TD-E6vTxrTaFhkmtJFaN-R5XSb7SXOkROwVzEPPFtAMlfnI-P1b4fnW2HTM5Mv_AeMJedDXtd8yfkqONrfb9ArCqY1_XSznD5FVHVk
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Proquest Health & Medical Complete
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3JitVAsBlHEC_ibsZRWxA8SHjppJfkJM-Hw0MYTw68W9OrC5KMbxFmvt6qzuIEwWPSldC1dVV1V1UT8saVNYuxDDlXlcm5NbAORtnkhWdWxsYxG_FE9_yzXF_wTxuxOSLrsRYG0yrHNTEt1L5zuEe-AFONzn5R8YWxuAvg9ov3l79yvD8Kz1mHyzRukdusBLcCJFttptCLYWOnsWSmlosd7r5g8i2mE4GFz69nZil17_93jb5hpOYJlDcs0tl9cm9wJemy5_0DchTah-TO-XBY_oisVmChKIpY2FHTetqXqdAu0uXVYfsbAWk6W0_coRCdA589_YmpGvD0A8j9mFycffyyWufDnQm5Ew3f56ouvIOQogzRcyW8M9KL4IKsjJcCWFFaVkUnQpCMxcZ6hZWwIUDUBrwRRfWEHLddG54RCjTD30RlmoZj13Zfg7dSVLVpVOkLm5F3I8n0Zd8aQ6eQopa6J7AGAutEYH2dkQ9I1QkS21qnF932qx60RKvoLYOZ1dFZ3oTGOgNYMO6jrEByREZeIU90XyM6KadeSgFuCPiWMiNvEwSqJwqJGaoMACVsdDWDPJ1Bglq5-fDIdz2o9U7_FcKMvJ6G8UtMVWtDd0gwjKtGKJWRp72YTEhX2B-xlICHmgnQjCrzkfb7t9T0W2EFMhMn_5_Wc3K37KU6Z9UpOd5vD-EFeE17-zIpxB_ufBaJ
  priority: 102
  providerName: ProQuest
Title Case series and review of Ayurvedic medication induced liver injury
URI https://www.ncbi.nlm.nih.gov/pubmed/33714265
https://www.proquest.com/docview/2502619034/abstract/
https://search.proquest.com/docview/2501479577
https://pubmed.ncbi.nlm.nih.gov/PMC7956115
https://doaj.org/article/7fdb1e618fcb49e9bcad4714df636f95
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9xADBZJCiGX0HfcplsXCj0UZ23Pyz7uLgmhsCGEBpZeBs-rTUi8YR-F5tdXM7aXNbnlYrBHNjPSJ0vySDLAV50XmXO5TaggVUJVhe9Bx8skNZnirtSZcn5Hd3rBz6_pjxmb7QDramFC0r5WNyf13f1JffMn5FY-3Othlyc2vJxOhK_GzNhwF3YFIVsh-m3o35IRQVhXIFPw4dJ_a_Gptj55CO158ngA-8S3qsu9TdmyR6Ft_9OX85Z16mdObpmis5dw2PqQ8aiZ6yvYsfVr2J-2u-RvYDJB0xR7bNllXNUmbupT4rmLR__Wi7-eMA6b6kEsMYblKGAT3_kcDTy7RT6_heuz05-T86T9WUKiWUlXiShSozGWyK0zVDCjK26Y1ZaTynCGMshVRpxm1iLrXKmM8CWw1mK4hkJhKXkHe_W8tkcQCzTi-BgnqrKkvl27KdBNSUlRlSI3qYrge8cy-dD0xJAhlii4bHgtkdcy8Fo-RjD2XN1Q-n7W4cJ88Vu2UpXCGZXhzAqnFS1tqXSFq8iocZwgZFgEn71MZFMcutFKOeIM_Q90KnkE3wKF10sUja7a8gJcku9w1aM87lGiPun-cCd32erzUqKj6EPNlNAIvmyG_Z0-R62283WgyShCU4gI3jcw2Sy6Q1sEogegHlf6Iwj-0O27BfuHZ9_5EQ7yBvtJRo5hb7VY20_oSa3UAPVnJgbwYnx6cXk1CN8j8Hg1_jUIOvUf6b0g-g
link.rule.ids 230,315,733,786,790,870,891,2115,12083,21416,27957,27958,31754,31755,33779,33780,43345,43840,53827,53829
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1ra9RAcNErqF_Et9FqVxD8IKHZZB_JJ7keLaf2DpEW-m3JvnwgSb2HYH-9M8lebBD8mOwk7M5jZ2bnsYS8tnnJQsh9ylVRp9zUsA8GWaWZY0aGyjITMKK7WMr5Of9wIS7igds6plXu9sRuo3atxTPyQ1DVaOxnBX93-TPFW6Mwuhqv0LhJ9ngBrsqE7B0dLz99HuII2NBpVypTysM1nrpg0i2mEYFmT69G6qjr2v_v3nxNOY0TJ69popN75G40Iem0p_l9csM3D8itRQySPySzGWgmiqzl17RuHO3LU2gb6PT3dvULAWkXU--oQsErB_o6-gNTNODpO6D5ETk_OT6bzdN4V0JqRcU3qSozZ8GVyH1wXAlna-mEt14WtZMCSJAbVgQrvJeMhco4hRWw3oO3BjQRWfGYTJq28U8JBZzhb4Kqq4pjt3ZXgpWSFWVdqdxlJiFvdyjTl31LDN25EqXUPYI1IFh3CNZXCTlCrA6Q2M66e9GuvugoHVoFZxjMrAzW8MpXxtawCsZdkAVwjEjIAdJE97Whg1DqqRRgfoBNKRPypoNAsQTS2DpWF8CSsMHVCHJ_BAniZMfDO7rrKM5r_Zf5EvJqGMYvMUWt8e22g2FcVUKphDzp2WRYdIF9EXMJ61AjBhphZTzSfPvaNftWWHnMxLP_T-uA3J6fLU716fvlx-fkTt5zeMqKfTLZrLb-BVhOG_MyiscfjdMXIg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB5BkaJeyhsMhRoJiQNy_Fjvrn0Mgag8UvVApYrLyvuCvpwoDyTy65ld21EMtx6THUcef9_szGRnxgBvVVak1mYmyjmpolxWuA9aVkaJTiWzpUqldSe60xN2fJZ_OafnO6_68kX7Sl4M6-ubYX3xy9dWzm9U3NWJxafTMXfdmCmN59rGd-Ee2mxW7iTql36KS0o4oV2bTMHipfvHxRXcuhIi9OrRZh8GxA2sy5xn2fFKfnj__1v0jo_q10_uOKTJffjRqdLUoVwN1ys5VJt_pjzeStcHcNCGqeGoEXkId0z9CAbT9iD-MYzH6P1CR1-zDKtah00LTDiz4ejPevHbCYb-3N4jH2LmjxzS4bUrA8FPlwjlEzibfPo-Po7a9zFEipb5KuJFohWmK5mxOudUq4ppapRhpNKMIsyZTIlV1Bi8Y1tKzV2XrTGYESLuNCFPYa-e1eY5hBzjBPwZy6uyzN1EeF1gJJSQoip5phMZwPsODzFvxm4In64UTDRACgRSeCDFJoAPDrKtpBuZ7b-YLX6K9mEKbrVM8c4Kq2RemlKqCrVIc20ZQVbSAI4c4KLpP90avhgxiiEOxq0sgHdewpk-4q6qtoMBVXJDtHqShz1JNFnVX-5IJdotYykwFnXZbELyAN5sl92VrgyuNrO1l0lzZATnATxrOLhVuqNyALzHzt5T6a8g5_xA8ZZjL2595REMTj9OxLfPJ19fwn7W2FiUkkPYWy3W5hXGbSv52lvoXzbVQO8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Case+series+and+review+of+Ayurvedic+medication+induced+liver+injury&rft.jtitle=BMC+complementary+medicine+and+therapies&rft.au=Karousatos%2C+Christopher+M&rft.au=Lee%2C+Justin+K&rft.au=Braxton%2C+David+R&rft.au=Fong%2C+Tse-Ling&rft.date=2021-03-13&rft.eissn=2662-7671&rft.volume=21&rft.issue=1&rft.spage=91&rft_id=info:doi/10.1186%2Fs12906-021-03251-z&rft_id=info%3Apmid%2F33714265&rft.externalDocID=33714265
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2662-7671&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2662-7671&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2662-7671&client=summon